{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:39:38Z","timestamp":1788874778383,"version":"build-2803163510"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>Latent class assignment-derived subphenotyping algorithms may identify treatment-responsive subgroups of critically ill patients with sepsis and acute respiratory distress syndrome. It is unclear if these algorithms are generalizable to patients with comorbid malignancy, a state which may perturb influential inflammatory biomarkers. This study aimed to test whether malignancy or neutropenia modified the effect of subphenotype assignment by two algorithms as applied to a prospective cohort enriched for ICU patients with active malignancy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>Prospective cohort study at a single U.S. quaternary referral center.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting\/Patients:<\/jats:title>\n                    <jats:p>ICU patients older than 18 admitted to an ICU with a primary admission indication of sepsis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>None.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results:<\/jats:title>\n                    <jats:p>\n                      We applied two published subphenotyping algorithms utilizing either interleukin (IL)-6 or IL-8 (in addition to soluble tumor necrosis factor receptor 1 and bicarbonate) to our cohort of 930 patients with sepsis, 396 (42%) of whom had active malignancy. A greater proportion of hematologic malignancy patients were assigned the \u201chyperinflammatory\u201d subphenotype by the IL-8-utilizing algorithm than the IL-6 algorithm (58% vs. 32%). Patients with leukemia and neutropenia were overrepresented among those classified as hyperinflammatory by IL-8 algorithm. We constructed Cox proportional hazards models to assess for interaction between the presence of solid malignancy, hematologic malignancy, and severe neutropenia and the subphenotype\/mortality association. Hematologic malignancy uniquely appeared to attenuate the associated mortality of the IL-6-assigned hyperinflammatory subphenotype (interaction;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.037), but not the IL-8-assigned hyperinflammatory subphenotype (interaction;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.260), which retained an independent association with mortality in hematologic malignancy subjects (hazard ratio, 1.50; 95% CI, 1.08\u20132.07;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.014).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>As subphenotyping algorithms are being tested as point-of-care prognostic tools, it is important to understand their generalizability to patients with comorbid malignancy, which constitute an increasing proportion of ICU patients. The differential behavior of these algorithms in patients with hematologic malignancy suggests a need for independent derivation and validation in this specific population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ccm.0000000000006774","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T14:13:18Z","timestamp":1752156798000},"page":"e2415-e2428","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Parsimonious Subphenotyping Algorithms Perform Differently in Patients With Sepsis and Hematologic Malignancy"],"prefix":"10.1097","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2310-5345","authenticated-orcid":false,"given":"Lukas","family":"Ronner","sequence":"first","affiliation":[{"name":"Division of Hematology and Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather M.","family":"Giannini","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine and Center for Translational Lung Biology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd A.","family":"Miano","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline A. G.","family":"Ittner","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine and Center for Translational Lung Biology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra P.","family":"Turner","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine and Center for Translational Lung Biology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas G.","family":"Dunn","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine and Center for Translational Lung Biology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roseline S.","family":"Agyekum","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine and Center for Translational Lung Biology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anushka","family":"Dasgupta","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine and Center for Translational Lung Biology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirstin","family":"West","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine and Center for Translational Lung Biology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffanie K.","family":"Jones","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine and Center for Translational Lung Biology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA"},{"name":"Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G. S.","family":"Shashaty","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine and Center for Translational Lung Biology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Reilly","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine and Center for Translational Lung Biology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuala J.","family":"Meyer","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine and Center for Translational Lung Biology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"key":"R1-20251204","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S2213-2600(14)70097-9","article-title":"Subphenotypes in acute respiratory distress syndrome: Latent class analysis of data from two randomised controlled trials.","volume":"2","author":"Calfee","year":"2014","journal-title":"Lancet Respir Med"},{"key":"R2-20251204","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/thoraxjnl-2021-217158","article-title":"Latent class analysis-derived subphenotypes are generalisable to observational cohorts of acute respiratory distress syndrome: A prospective study.","volume":"77","author":"Sinha","year":"2022","journal-title":"Thorax"},{"key":"R3-20251204","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1136\/thoraxjnl-2016-209719","article-title":"Identification and validation of distinct biological phenotypes in patients with acute respiratory distress syndrome by cluster analysis.","volume":"72","author":"Bos","year":"2017","journal-title":"Thorax"},{"key":"R4-20251204","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S2213-2600(20)30366-0","article-title":"Prevalence of phenotypes of acute respiratory distress syndrome in critically ill patients with COVID-19: A prospective observational study.","volume":"8","author":"Sinha","year":"2020","journal-title":"Lancet Respir Med"},{"key":"R5-20251204","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1097\/CCM.0000000000004018","article-title":"Host-response subphenotypes offer prognostic enrichment in patients with or at risk for acute respiratory distress syndrome.","volume":"47","author":"Kitsios","year":"2019","journal-title":"Crit Care Med"},{"key":"R6-20251204","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev-med-043021-014005","article-title":"Biological phenotyping in sepsis and acute respiratory distress syndrome.","volume":"74","author":"Sinha","year":"2023","journal-title":"Annu Rev Med"},{"key":"R7-20251204","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1164\/rccm.201603-0645OC","article-title":"Acute respiratory distress syndrome subphenotypes respond differently to randomized fluid management strategy.","volume":"195","author":"Famous","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"R9-20251204","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s13054-020-02866-x","article-title":"Two subphenotypes of septic acute kidney injury are associated with different 90-day mortality and renal recovery.","volume":"24","author":"Wiersema","year":"2020","journal-title":"Crit Care"},{"key":"R10-20251204","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1164\/rccm.202006-2522OC","article-title":"Biological subphenotypes of acute respiratory distress syndrome show prognostic enrichment in mechanically ventilated patients without acute respiratory distress syndrome.","volume":"203","author":"Heijnen","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"R11-20251204","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S2213-2600(23)00237-0","article-title":"Identifying molecular phenotypes in sepsis: An analysis of two prospective observational cohorts and secondary analysis of two randomised controlled trials.","volume":"11","author":"Sinha","year":"2023","journal-title":"Lancet Respir Med"},{"key":"R12-20251204","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S2213-2600(19)30369-8","article-title":"Development and validation of parsimonious algorithms to classify acute respiratory distress syndrome phenotypes: A secondary analysis of randomised controlled trials.","volume":"8","author":"Sinha","year":"2020","journal-title":"Lancet Respir Med"},{"key":"R13-20251204","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJMoa032193","article-title":"Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome.","volume":"351","author":"Brower","year":"2004","journal-title":"N Engl J Med"},{"key":"R14-20251204","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa1403285","article-title":"Simvastatin in the acute respiratory distress syndrome.","volume":"371","author":"McAuley","year":"2014","journal-title":"N Engl J Med"},{"key":"R15-20251204","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1164\/rccm.202108-1908ST","article-title":"A research agenda for precision medicine in sepsis and acute respiratory distress syndrome: An official American Thoracic Society Research Statement.","volume":"204","author":"Shah","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"R16-20251204","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1164\/rccm.202311-2086SO","article-title":"From ICU syndromes to ICU subphenotypes: Consensus report and recommendations for developing precision medicine in ICU.","volume":"210","author":"Gordon","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"R18-20251204","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s00134-008-1320-4","article-title":"Continued survival gains in recent years among critically ill myeloma patients.","volume":"35","author":"Peigne","year":"2009","journal-title":"Intensive Care Med"},{"key":"R19-20251204","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1200\/JCO.2016.66.9549","article-title":"Effects of organizational characteristics on outcomes and resource use in patients with cancer admitted to intensive care units.","volume":"34","author":"Soares","year":"2016","journal-title":"J Clin Oncol"},{"key":"R20-20251204","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1007\/s00134-017-4884-z","article-title":"The Intensive Care Medicine research agenda on critically ill oncology and hematology patients.","volume":"43","author":"Azoulay","year":"2017","journal-title":"Intensive Care Med"},{"key":"R21-20251204","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1007\/s00134-021-06502-2","article-title":"Critical illness in patients with hematologic malignancy: A population-based cohort study.","volume":"47","author":"Ferreyro","year":"2021","journal-title":"Intensive Care Med"},{"key":"R22-20251204","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/SHK.0000000000001203","article-title":"Murine pancreatic cancer alters T cell activation and apoptosis and worsens survival after cecal ligation and puncture.","volume":"51","author":"Lyons","year":"2019","journal-title":"Shock"},{"key":"R23-20251204","doi-asserted-by":"crossref","first-page":"e139823","DOI":"10.1172\/jci.insight.139823","article-title":"TIGIT modulates sepsis-induced immune dysregulation in mice with preexisting malignancy.","volume":"6","author":"Zhang","year":"2021","journal-title":"JCI Insight"},{"key":"R24-20251204","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/JLB.3A1019-502R","article-title":"Preexisting malignancy abrogates the beneficial effects of CXCR4 blockade during sepsis.","volume":"107","author":"Zhang","year":"2020","journal-title":"J Leukoc Biol"},{"key":"R25-20251204","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s13054-016-1398-y","article-title":"Neutropenic sepsis is associated with distinct clinical and biological characteristics: A cohort study of severe sepsis.","volume":"20","author":"Reilly","year":"2016","journal-title":"Crit Care"},{"key":"R26-20251204","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM200005043421801","article-title":"Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome.","volume":"342","author":"Brower","year":"2000","journal-title":"N Engl J Med"},{"key":"R27-20251204","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1056\/NEJMoa062200","article-title":"Comparison of two fluid-management strategies in acute lung injury.","volume":"354","author":"Weidemann","year":"2006","journal-title":"N Engl J Med"},{"key":"R28-20251204","doi-asserted-by":"crossref","first-page":"100817","DOI":"10.1016\/j.xcrm.2022.100817","article-title":"Toward personalized immunotherapy in sepsis: The PROVIDE randomized clinical trial.","volume":"3","author":"Leventogiannis","year":"2022","journal-title":"Cell Rep Med"},{"key":"R29-20251204","doi-asserted-by":"crossref","first-page":"e067251","DOI":"10.1136\/bmjopen-2022-067251","article-title":"ImmunoSep (Personalised Immunotherapy in Sepsis) international double-blind, double-dummy, placebo-controlled randomised clinical trial: Study protocol.","volume":"12","author":"Kotsaki","year":"2022","journal-title":"BMJ Open"},{"key":"R30-20251204","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s00134-003-1662-x","article-title":"2001 SCCM\/ESICM\/ACCP\/ATS\/SIS international sepsis definitions conference.","volume":"29","author":"Levy","year":"2003","journal-title":"Intensive Care Med"},{"key":"R31-20251204","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3).","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"R32-20251204","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1186\/s13054-019-2684-2","article-title":"Plasma sTNFR1 and IL8 for prognostic enrichment in sepsis trials: A prospective cohort study.","volume":"23","author":"Anderson","year":"2019","journal-title":"Crit Care"},{"key":"R33-20251204","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1080\/03610910902859574","article-title":"Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research.","volume":"38","author":"Austin","year":"2009","journal-title":"Commun Stat Simul Comput"},{"key":"R34-20251204","doi-asserted-by":"crossref","first-page":"e12047","DOI":"10.1002\/cesm.12047","article-title":"Standardized mean differences in meta-analysis: A tutorial.","volume":"2","author":"Gallardo-G\u00f3mez","year":"2024","journal-title":"Cochrane Evid Synth Methods"},{"key":"R36-20251204","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10654-019-00494-6","article-title":"Principles of confounder selection.","volume":"34","author":"VanderWeele","year":"2019","journal-title":"Eur J Epidemiol"},{"key":"R37-20251204","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1007\/s00134-022-06811-0","article-title":"Association of vancomycin plus piperacillin-tazobactam with early changes in creatinine versus cystatin C in critically ill adults: A prospective cohort study.","volume":"48","author":"Miano","year":"2022","journal-title":"Intensive Care Med"},{"key":"R38-20251204","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/SHK.0000000000001833","article-title":"Elevated plasma levels of matrix metalloproteinase-3 and tissue-inhibitor of matrix metalloproteinases-1 associate with organ dysfunction and mortality in sepsis.","volume":"57","author":"Jones","year":"2022","journal-title":"Shock (Augusta, GA)"},{"key":"R39-20251204","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1158\/0008-5472.CAN-16-1095","article-title":"MIF-induced stromal PKC\u03b2\/IL8 is essential in human acute myeloid leukemia.","volume":"77","author":"Abdul-Aziz","year":"2017","journal-title":"Cancer Res"},{"key":"R40-20251204","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1097\/01.TP.0000135564.82707.F0","article-title":"Interleukin-8, neutropenia, and graft failure in human stem cell transplantation.","volume":"78","author":"Schwabe","year":"2004","journal-title":"Transplantation"},{"key":"R41-20251204","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1182\/blood.V93.4.1157","article-title":"Endogenous interleukin-8 (IL-8) surge in granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilization.","volume":"93","author":"Watanabe","year":"1999","journal-title":"Blood"},{"key":"R42-20251204","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1200\/JCO.2012.47.2365","article-title":"Outcomes of critically ill patients with hematologic malignancies: Prospective multicenter data from France and Belgium\u2014a groupe de recherche respiratoire en r\u00e9animation onco-h\u00e9matologique study.","volume":"31","author":"Azoulay","year":"2013","journal-title":"J Clin Oncol"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000006774","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T16:01:47Z","timestamp":1764864107000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000006774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000006774","relation":{},"ISSN":["0090-3493","1530-0293"],"issn-type":[{"value":"0090-3493","type":"print"},{"value":"1530-0293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,10]]}}}